MeSH Review:
Uterine Diseases
- Serum interleukin-6 levels in uterine malignancies. Preliminary data. Ferdeghini, M., Gadducci, A., Prontera, C., Bonuccelli, A., Annicchiarico, C., Fanucchi, A., Facchini, V., Bianchi, R. Anticancer Res. (1994)
- Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervix. Ferdeghini, M., Gadducci, A., Annicchiarico, C., Prontera, C., Malagnino, G., Castellani, C., Facchini, V., Bianchi, R. Anticancer Res. (1993)
- Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Bulun, S.E., Lin, Z., Imir, G., Amin, S., Demura, M., Yilmaz, B., Martin, R., Utsunomiya, H., Thung, S., Gurates, B., Tamura, M., Langoi, D., Deb, S. Pharmacol. Rev. (2005)
- Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study. Mahon, M.M., deSouza, N.M., Dina, R., Soutter, W.P., McIndoe, G.A., Williams, A.D., Cox, I.J. NMR in biomedicine. (2004)
- Oestrogens prevent the increase of human serum soluble interleukin-6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro. Girasole, G., Giuliani, N., Modena, A.B., Passeri, G., Pedrazzoni, M. Clin. Endocrinol. (Oxf) (1999)
- Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data. Ferdeghini, M., Gadducci, A., Prontera, C., Marrai, R., Malagnino, G., Annicchiarico, C., Fioretti, P., Bianchi, R. Anticancer Res. (1993)